School of Pharmacy professor receives new contract from GlaxoSmithKline.
Susan dosReis, PhD, professor in the Department of Pharmaceutical Health Services Research (PHSR), has received a five-year $3.7 million contract from GlaxoSmithKline for “A Targeted Safety Study, EPI-ZOSTER-032 VS, to Evaluate the Safety of Shingrix in Adults ≥ 65 Years of Age in the United States.”